<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="587">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05153512</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A01354-51</org_study_id>
    <nct_id>NCT05153512</nct_id>
  </id_info>
  <brief_title>ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)</brief_title>
  <acronym>Adodream</acronym>
  <official_title>ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To date, no MRI study has been published describing the prevalence of endometriosis in&#xD;
      adolescent girls, not even in those with significant dysmenorrhea and therefore more&#xD;
      particularly at risk. Likewise, there are no precise data on the type of superficial or&#xD;
      early-onset deep endometriosis that appears in adolescence. The collection of these data&#xD;
      would allow an earlier diagnosis, because it is better documented, of endometriosis. The&#xD;
      lesions would then be treated earlier, avoiding their development and the problems of&#xD;
      infertility related to this pathology. The aim of this sudy is to assess the prevalence of&#xD;
      endometriosis and its phenotypic representation in the study population consulting for&#xD;
      dysmenorrhea with suspected endometriosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2019</start_date>
  <completion_date type="Anticipated">December 26, 2021</completion_date>
  <primary_completion_date type="Actual">June 26, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patient with endometriosis detected on MRI</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Endometriosis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Pelvic MRI without injection of contrast product and WITHOUT rectal or vaginal opacification</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women between 12 and 20 years-old and suffering from dysmenorrhea&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged between 12 and 20 years old.&#xD;
&#xD;
          -  After menarche.&#xD;
&#xD;
          -  Requiring pelvic MRI for exploration of dysmenorrhea (after or not ultrasound), in the&#xD;
             case of patients with suspected endometriosis, or for any other reason (cyst, tumor,&#xD;
             non-obstructive urogenital malformations), in the case of patients without symptoms&#xD;
             clinic associated with endometriosis.&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security scheme.&#xD;
&#xD;
          -  Patient and her legal representative, if applicable, having been informed and not&#xD;
             opposing this research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient whose pelvic MRI is performed as part of an exploration of obstructive uterine&#xD;
             malformations.&#xD;
&#xD;
          -  Patient claustrophobic, making it impossible to perform an MRI.&#xD;
&#xD;
          -  Contraindication to MRI: pacemaker, ferromagnetic object incompatible with MRI.&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient woman.&#xD;
&#xD;
          -  Protected patient: Major under guardianship, curatorship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision; Hospitalized without&#xD;
             consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>20 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BLOMET clinic</name>
      <address>
        <city>Paris</city>
        <state>IDF</state>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Barba</last_name>
      <phone>+330664888704</phone>
      <phone_ext>+330664888704</phone_ext>
      <email>mh.barba@ecten.eu</email>
    </contact>
    <contact_backup>
      <last_name>Jean Francois OUDET</last_name>
      <phone>+33683346567</phone>
      <phone_ext>+33683346567</phone_ext>
      <email>jf.oudet@ecten.eu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 25, 2021</study_first_submitted>
  <study_first_submitted_qc>December 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>December 9, 2021</last_update_submitted>
  <last_update_submitted_qc>December 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Dysmenorrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

